English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
13 天
永泰生物-B (06978) 计划将于近期提交关于 EAL 的新药上市申请
2月28日, 永泰生物-B ( 4.42, -0.10, -2.21%) (06978) 发布公告,更新其核心产品候选药物EAL®的最新进展。根据近期与中国国家药品监督管理局药品审评中心 (CDE)的沟通,CDE已同意公司提交EAL®的附条件批准申请。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Deportation order blocked
US launches strikes in Yemen
Pleads not guilty
Chiefs sign Tillery
Kellogg's envoy role reduced
Wins longest-ever Iditarod
Coffee creamer recall
Laceration hazard recall
Severe weather outbreak
Israeli attack in Gaza
Syed formally resentenced
Withdraws nomination
Gold rises to new heights
Trump signs funding bill
Influencer leaves Australia
US expels SA ambassador
Kupp signs with Seahawks
Electrical fire halts show
SK: Massive rallies erupt
Second protester arrested
Felony gun possession arrest
Child abuse images sentence
Villanova fires coach Neptune
Permanently shuts route
Man wins $50M over burns
Cuba suffers power outage
Texas measles outbreak
RU, UKR launch attacks
反馈